Search:
Home | Register or Login | Contact Us

Literature Summaries More

Exenatide Therapy in Obese Patients With Type 2 Diabetes Mellitus Treated With Insulin
Viswanathan P, Chaudhuri A, Bhatia R, Al-Atrash F, Mohanty P, Dandona P. Endocr Pract. 2007;13:444-450.

Results of the Glucose-Lowering Effect of Welchol Study (GLOWS): a Randomized, Double-Blind, Placebo-Controlled Pilot Study Evaluating the Effect of Colesevelam Hydrochloride on Glycemic Control in Subjects With Type 2 Diabetes
Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL. Clin Ther. 2007;29:74-83.

Impact of Fasting and Postprandial Glycemia on Overall Glycemic Control in Type 2 Diabetes: Importance of Postprandial Glycemia to Achieve Target Hba1c Levels
Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Goke B. Diabetes Res Clin Pract. 2007;77:280-285.


 

 
SPOTLIGHT ON TYPE 2 DIABETES
Articles:
Epidemiology and Disease Pathology of Type 2 Diabetes
Screening and Diagnosis of Type 2 Diabetes
Treatment of Type 2 Diabetes
Insulin Therapy
Glucagon-Like Peptide 1 Receptor Agonists: A Novel Treatment for Type 2 Diabetes
CME-Certified Activities:
Much Ado About Inpatient Insulin therapy
Clinical Practice Poll
In your opinion, where do incretin mimetics fit into the treatment paradigm for type 2 diabetes?
First-line monotheray
First-line combination therapy with oral agents
After failing 1 oral agent
After failing 2 oral agents
About Us | Terms of Use | Privacy Statement | Disclaimer